Chapter/Section Purchase

1 Study Coverage
1.1 Heart Failure Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Heart Failure Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 ACEI
1.2.3 Angiotensin II Receptor Blockers
1.2.4 ARNIs
1.2.5 Beta Blockers
1.2.6 Aldosterone Antagonists
1.2.7 Diuretics
1.3 Market by Application
1.3.1 Global Heart Failure Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Reduced Ejection Fraction
1.3.3 Preserved Ejection Fraction
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Heart Failure Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global Heart Failure Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global Heart Failure Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Heart Failure Drugs Sales by Region
2.4.1 Global Heart Failure Drugs Sales by Region (2017-2022)
2.4.2 Global Sales Heart Failure Drugs by Region (2023-2028)
2.5 Global Heart Failure Drugs Revenue by Region
2.5.1 Global Heart Failure Drugs Revenue by Region (2017-2022)
2.5.2 Global Heart Failure Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Heart Failure Drugs Sales by Manufacturers
3.1.1 Global Top Heart Failure Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global Heart Failure Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Heart Failure Drugs in 2021
3.2 Global Heart Failure Drugs Revenue by Manufacturers
3.2.1 Global Heart Failure Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global Heart Failure Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Heart Failure Drugs Revenue in 2021
3.3 Global Heart Failure Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Heart Failure Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Heart Failure Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Heart Failure Drugs Sales by Type
4.1.1 Global Heart Failure Drugs Historical Sales by Type (2017-2022)
4.1.2 Global Heart Failure Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global Heart Failure Drugs Sales Market Share by Type (2017-2028)
4.2 Global Heart Failure Drugs Revenue by Type
4.2.1 Global Heart Failure Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global Heart Failure Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global Heart Failure Drugs Revenue Market Share by Type (2017-2028)
4.3 Global Heart Failure Drugs Price by Type
4.3.1 Global Heart Failure Drugs Price by Type (2017-2022)
4.3.2 Global Heart Failure Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Heart Failure Drugs Sales by Application
5.1.1 Global Heart Failure Drugs Historical Sales by Application (2017-2022)
5.1.2 Global Heart Failure Drugs Forecasted Sales by Application (2023-2028)
5.1.3 Global Heart Failure Drugs Sales Market Share by Application (2017-2028)
5.2 Global Heart Failure Drugs Revenue by Application
5.2.1 Global Heart Failure Drugs Historical Revenue by Application (2017-2022)
5.2.2 Global Heart Failure Drugs Forecasted Revenue by Application (2023-2028)
5.2.3 Global Heart Failure Drugs Revenue Market Share by Application (2017-2028)
5.3 Global Heart Failure Drugs Price by Application
5.3.1 Global Heart Failure Drugs Price by Application (2017-2022)
5.3.2 Global Heart Failure Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America Heart Failure Drugs Market Size by Type
6.1.1 North America Heart Failure Drugs Sales by Type (2017-2028)
6.1.2 North America Heart Failure Drugs Revenue by Type (2017-2028)
6.2 North America Heart Failure Drugs Market Size by Application
6.2.1 North America Heart Failure Drugs Sales by Application (2017-2028)
6.2.2 North America Heart Failure Drugs Revenue by Application (2017-2028)
6.3 North America Heart Failure Drugs Market Size by Country
6.3.1 North America Heart Failure Drugs Sales by Country (2017-2028)
6.3.2 North America Heart Failure Drugs Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Heart Failure Drugs Market Size by Type
7.1.1 Europe Heart Failure Drugs Sales by Type (2017-2028)
7.1.2 Europe Heart Failure Drugs Revenue by Type (2017-2028)
7.2 Europe Heart Failure Drugs Market Size by Application
7.2.1 Europe Heart Failure Drugs Sales by Application (2017-2028)
7.2.2 Europe Heart Failure Drugs Revenue by Application (2017-2028)
7.3 Europe Heart Failure Drugs Market Size by Country
7.3.1 Europe Heart Failure Drugs Sales by Country (2017-2028)
7.3.2 Europe Heart Failure Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Heart Failure Drugs Market Size by Type
8.1.1 Asia Pacific Heart Failure Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific Heart Failure Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific Heart Failure Drugs Market Size by Application
8.2.1 Asia Pacific Heart Failure Drugs Sales by Application (2017-2028)
8.2.2 Asia Pacific Heart Failure Drugs Revenue by Application (2017-2028)
8.3 Asia Pacific Heart Failure Drugs Market Size by Region
8.3.1 Asia Pacific Heart Failure Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific Heart Failure Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Heart Failure Drugs Market Size by Type
9.1.1 Latin America Heart Failure Drugs Sales by Type (2017-2028)
9.1.2 Latin America Heart Failure Drugs Revenue by Type (2017-2028)
9.2 Latin America Heart Failure Drugs Market Size by Application
9.2.1 Latin America Heart Failure Drugs Sales by Application (2017-2028)
9.2.2 Latin America Heart Failure Drugs Revenue by Application (2017-2028)
9.3 Latin America Heart Failure Drugs Market Size by Country
9.3.1 Latin America Heart Failure Drugs Sales by Country (2017-2028)
9.3.2 Latin America Heart Failure Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Heart Failure Drugs Market Size by Type
10.1.1 Middle East and Africa Heart Failure Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa Heart Failure Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa Heart Failure Drugs Market Size by Application
10.2.1 Middle East and Africa Heart Failure Drugs Sales by Application (2017-2028)
10.2.2 Middle East and Africa Heart Failure Drugs Revenue by Application (2017-2028)
10.3 Middle East and Africa Heart Failure Drugs Market Size by Country
10.3.1 Middle East and Africa Heart Failure Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa Heart Failure Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Novartis
11.1.1 Novartis Corporation Information
11.1.2 Novartis Overview
11.1.3 Novartis Heart Failure Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Novartis Heart Failure Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Novartis Recent Developments
11.2 Pfizer
11.2.1 Pfizer Corporation Information
11.2.2 Pfizer Overview
11.2.3 Pfizer Heart Failure Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Pfizer Heart Failure Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Pfizer Recent Developments
11.3 AstraZeneca
11.3.1 AstraZeneca Corporation Information
11.3.2 AstraZeneca Overview
11.3.3 AstraZeneca Heart Failure Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 AstraZeneca Heart Failure Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 AstraZeneca Recent Developments
11.4 Hikma
11.4.1 Hikma Corporation Information
11.4.2 Hikma Overview
11.4.3 Hikma Heart Failure Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Hikma Heart Failure Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Hikma Recent Developments
11.5 Teva
11.5.1 Teva Corporation Information
11.5.2 Teva Overview
11.5.3 Teva Heart Failure Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Teva Heart Failure Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Teva Recent Developments
11.6 Cipla
11.6.1 Cipla Corporation Information
11.6.2 Cipla Overview
11.6.3 Cipla Heart Failure Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Cipla Heart Failure Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Cipla Recent Developments
11.7 Merck & Co.
11.7.1 Merck & Co. Corporation Information
11.7.2 Merck & Co. Overview
11.7.3 Merck & Co. Heart Failure Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Merck & Co. Heart Failure Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Merck & Co. Recent Developments
11.8 Amgen
11.8.1 Amgen Corporation Information
11.8.2 Amgen Overview
11.8.3 Amgen Heart Failure Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Amgen Heart Failure Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Amgen Recent Developments
11.9 Roche
11.9.1 Roche Corporation Information
11.9.2 Roche Overview
11.9.3 Roche Heart Failure Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Roche Heart Failure Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Roche Recent Developments
11.10 Sun Pharma
11.10.1 Sun Pharma Corporation Information
11.10.2 Sun Pharma Overview
11.10.3 Sun Pharma Heart Failure Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Sun Pharma Heart Failure Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Sun Pharma Recent Developments
11.11 Mylan
11.11.1 Mylan Corporation Information
11.11.2 Mylan Overview
11.11.3 Mylan Heart Failure Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Mylan Heart Failure Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Mylan Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Heart Failure Drugs Industry Chain Analysis
12.2 Heart Failure Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Heart Failure Drugs Production Mode & Process
12.4 Heart Failure Drugs Sales and Marketing
12.4.1 Heart Failure Drugs Sales Channels
12.4.2 Heart Failure Drugs Distributors
12.5 Heart Failure Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Heart Failure Drugs Industry Trends
13.2 Heart Failure Drugs Market Drivers
13.3 Heart Failure Drugs Market Challenges
13.4 Heart Failure Drugs Market Restraints
14 Key Findings in The Global Heart Failure Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer